Allergy Clinical Trial
Official title:
Correlation of Nasal Volume and Cross-Sectional Area With Nasalance Scores as Measured by Acoustic Rhinometry and Nasometry
The purpose of our study is to correlate nasal volume and cross-sectional area with
nasalance scores. We will measure nasal volume and cross-sectional area with acoustic
rhinometry. Nasalance scores will be determined by Nasometry.
Acoustic rhinometry is a means to study the volume and cross-sectional areas of the nasal
cavity in a non-invasive, rapid, convenient and reliable manner. Acoustic rhinometry has the
unique advantage of being completely non-invasive, and thus is able to measure nasal patency
without the confounding effects of probes or invasive monitoring.
Nasometry is a technique to measure the oral and nasal components of nasalance. Nasalance is
the objective measure of the nasal component of speech that is determined by the ratio of
sound pressure emitted from the nasal and oral cavities during speech. Nasality is the term
used to characterize the nasal component of speech, and is a subjective measure.
Eleven healthy subjects underwent acoustic rhinometry pre and post decongestion using
oxymetazoline 0.05% nasal spray. Nasalance scores were based on the readings of three
passages: rainbow, zoo, and nasal.
Acoustic rhinometry is a technique that utilizes sound waves to measure nasal patency. The
reflections of the waves off of the nasal structures allow one to assess the volume and
cross sectional area of the nasal cavity. It is a non-invasive procedure that can be
performed in a rapid, convenient, and reliable manner. There is minimal discomfort for the
patient and it can be performed easily in the office. There is no distortion of nasal
anatomy or functioning as a result of the procedure.
Nasometry is a technique to measure the oral and nasal components of nasalance. Nasalance is
an objective measure of the nasal component of speech that is determined by the ratio of
acoustic pressures emitted from the nasal and oral cavities. 'Nasality' is the term used to
characterize the nasal component of speech, and is a subjective measure.
The Nasometer (Kay Elemetrics Corp Lincoln Park, NJ) is a computer-based device that
analyzes acoustic energy that is emitted from the oral and the nasal cavity during speech.
It consists of two microphones that are separated by a plate. The upper microphone measures
nasally emitted acoustic energy, and the lower microphone measure the acoustic energy
emitted from the oral cavity.
Nasalance is an important measure in speech pathology. In situations where velopharyngeal
competence is in question, nasometry objectively documents the nasal component of speech as
normal, hypemasal or hyponasal. It has been found to be of tremendous benefit in the
management of patients with cleft palate and velopharyngeal incompetence. The subject is
relaxed, and is fitted with a headgear apparatus. This apparatus is placed such that a plate
lies in a horizontal plane that rests midway between the nose and the mouth. There are
microphones on the upper and lower surfaces of the plate that capture sound energy produced
from the nasal and oral cavities respectively. The subject is then asked to read standard
passages. The three most commonly used passages are described here, and will be used in our
study. The 'Rainbow' passage is most representative of standard English speech. The 'Zoo'
passage has no nasal consonants, and the 'Nasal' passage has the highest number of nasal
consonants.
While the subject is reading, the microphone captures sound pressure levels which are
emitted from the nasal and the oral cavities. This data is analyzed by the attached computer
and presented graphically. The computer also provides a nasalance score for each of three
above- mentioned passages. Normative data is available for each of these passages for adults
and children. By comparing the data obtained from the subject with the normative means and
standard deviations, the investigator can categorize the subject's voice as normal,
hyponasal or hypernasal. The nasalance score that is generated can also be used to monitor
the efficacy of speech therapy and surgical interventions.
;
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT02032056 -
Effect of Probiotics in Reducing Infections and Allergies in Young Children During the Complementary Feeding Period
|
N/A | |
Completed |
NCT01842711 -
Cumulative Irritation Patch Test
|
N/A | |
Completed |
NCT01633840 -
New Validated Recipes for Double-blind Placebo-controlled Low Dose Food Challenges
|
N/A | |
Completed |
NCT00997971 -
Growth, Tolerance in Healthy Infants Fed a Partially Hydrolyzed Rice Protein
|
Phase 3 | |
Completed |
NCT00554983 -
Efficacy and Safety From a Recombinant Folding Variant of Bet v 1
|
Phase 3 | |
Completed |
NCT00331929 -
Respiratory Health Study of Children in Kiryat Tivon
|
N/A | |
Completed |
NCT00220753 -
Air Cleaners for Children and Adolescents With Asthma and Dog Allergy
|
N/A | |
Completed |
NCT00232518 -
Randomised Controlled Clinical Trials of the Effect of Therapeutic Hookworm Infection in Allergic Rhinoconjunctivitis
|
N/A | |
Completed |
NCT04126096 -
Negative Predictive Value and NIC of Beta-Lactam Antibiotics.
|
N/A | |
Completed |
NCT04046731 -
Neuromuscular Blocking Agents Utilized During Perioperative Hypersensitivity Evaluation
|
N/A | |
Completed |
NCT04004351 -
Treatment Modalities in Children and Adolescents Suffering From HDM-induced Allergic Rhinitis and/or Asthma
|
||
Not yet recruiting |
NCT05997784 -
Study of Indoor Air Pollutants and Their Impact in Childhood Health and Wellbeing
|
||
Completed |
NCT04418999 -
Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus
|
Early Phase 1 | |
Completed |
NCT04186949 -
Early Origins of Allergy and Asthma
|
||
Completed |
NCT02127801 -
Single Ascending-dose Study of the Efficacy, Safety, Tolerability, and Pharmacokinetics of REGN1908-1909 in Allergic, Adult Participants
|
Phase 1 | |
Enrolling by invitation |
NCT05011071 -
The Alberta BLOOM Premature Child Study
|
||
Not yet recruiting |
NCT06330974 -
Allergy, Asthma, and Atopic Eczema in Finland
|
||
Completed |
NCT02306473 -
The Leaky Lung Test
|
Early Phase 1 | |
Terminated |
NCT02601690 -
Observational Analysis of T Cell Responses to SPIREs for Multiple Allergens in Subjects With Allergy in North America
|
||
Completed |
NCT02596321 -
A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK HDM Tablets in Adult Subjects With HDM-Induced Allergic Rhinitis and/or Atopic Asthma
|
Phase 3 |